These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26779769)

  • 21. Re-initiation of dabigatran and direct factor Xa antagonists after a major bleed.
    Milling TJ; Spyropoulos AC
    Am J Emerg Med; 2016 Nov; 34(11S):19-25. PubMed ID: 27697440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New oral anticoagulant-induced bleeding: clinical presentation and management.
    Levy JH; Levi M
    Clin Lab Med; 2014 Sep; 34(3):575-86. PubMed ID: 25168943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
    Ritzenthaler T; Derex L; Davenas C; Bnouhanna W; Farghali A; Mechtouff L; Cho TH; Nighoghossian N
    Rev Neurol (Paris); 2015 Sep; 171(8-9):613-5. PubMed ID: 25857461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society.
    Remy-Jardin M; Pistolesi M; Goodman LR; Gefter WB; Gottschalk A; Mayo JR; Sostman HD
    Radiology; 2007 Nov; 245(2):315-29. PubMed ID: 17848685
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute pulmonary embolism treatment with rivaroxaban results in a shorter duration of hospitalisation compared to standard therapy: an academic centre experience.
    Paczyńska M; Kurnicka K; Lichodziejewska B; Goliszek S; Dzikowska-Diduch O; Sobieraj P; Burzyński Ł; Kostrubiec M; Pruszczyk P; Ciurzyński M
    Kardiol Pol; 2016; 74(7):650-6. PubMed ID: 26779849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Warfarin and Newer Agents: What the Oral Surgeon Needs to Know.
    Steed MB; Swanson MT
    Oral Maxillofac Surg Clin North Am; 2016 Nov; 28(4):515-521. PubMed ID: 27624772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Monitoring options and reversal agents for oral anticoagulants].
    Thorup SB; Husted SE; Vang ML
    Ugeskr Laeger; 2014 Apr; 176(9):. PubMed ID: 25096568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utilization of catheter-directed thrombolysis in pulmonary embolism and outcome difference between systemic thrombolysis and catheter-directed thrombolysis.
    Patel N; Patel NJ; Agnihotri K; Panaich SS; Thakkar B; Patel A; Savani C; Patel N; Arora S; Deshmukh A; Bhatt P; Alfonso C; Cohen M; Tafur A; Elder M; Mohamed T; Attaran R; Schreiber T; Grines C; Badheka AO
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1219-27. PubMed ID: 26308961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editor's Choice - Prolonged ICU Length of Stay after AAA Repair: Analysis of Time Trends and Long-term Outcome.
    Gavali H; Mani K; Tegler G; Kawati R; Covaciu L; Wanhainen A
    Eur J Vasc Endovasc Surg; 2017 Aug; 54(2):157-163. PubMed ID: 28648757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Yao X; Abraham NS; Sangaralingham LR; Bellolio MF; McBane RD; Shah ND; Noseworthy PA
    J Am Heart Assoc; 2016 Jun; 5(6):. PubMed ID: 27412905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oral direct anticoagulants versus vitamin K antagonists for the treatment of pulmonary embolism].
    Kümler T
    Ugeskr Laeger; 2016 May; 178(18):. PubMed ID: 27137112
    [No Abstract]   [Full Text] [Related]  

  • 32. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
    Boda Z
    Orv Hetil; 2016 Mar; 157(12):443-50. PubMed ID: 26971644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in oral anticoagulant choice for acute stroke patients with nonvalvular atrial fibrillation in Japan: the SAMURAI-NVAF study.
    Toyoda K; Arihiro S; Todo K; Yamagami H; Kimura K; Furui E; Terasaki T; Shiokawa Y; Kamiyama K; Takizawa S; Okuda S; Okada Y; Kameda T; Nagakane Y; Hasegawa Y; Mochizuki H; Ito Y; Nakashima T; Takamatsu K; Nishiyama K; Kario K; Sato S; Koga M;
    Int J Stroke; 2015 Aug; 10(6):836-42. PubMed ID: 25581108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Variation in critical care unit admission rates and outcomes for patients with acute coronary syndromes or heart failure among high- and low-volume cardiac hospitals.
    van Diepen S; Bakal JA; Lin M; Kaul P; McAlister FA; Ezekowitz JA
    J Am Heart Assoc; 2015 Feb; 4(3):e001708. PubMed ID: 25725089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A cost-analysis model for anticoagulant treatment in the hospital setting.
    Mody SH; Huynh L; Zhuo DY; Tran KN; Lefebvre P; Bookhart B
    J Med Econ; 2014 Jul; 17(7):492-8. PubMed ID: 24773068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012.
    Piga M; Casula L; Perra D; Sanna S; Floris A; Antonelli A; Cauli A; Mathieu A
    Lupus; 2016 Jan; 25(1):28-37. PubMed ID: 26199283
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New oral anticoagulants--what the cardiothoracic surgeon needs to know.
    Kaneko T; Yammine M; Aranki SF
    J Thorac Cardiovasc Surg; 2014 Nov; 148(5):1794-1801.e1. PubMed ID: 24973923
    [No Abstract]   [Full Text] [Related]  

  • 38. Dabigatran "non-inferior" to warfarin, but only just.
    BMJ; 2013 Feb; 346():f1219. PubMed ID: 23447339
    [No Abstract]   [Full Text] [Related]  

  • 39. Factors Influencing Hospital Stay for Pulmonary Embolism. A Cohort Study.
    Rodríguez-Núñez N; Ruano-Raviña A; Abelleira R; Ferreiro L; Lama A; González-Barcala FJ; Golpe A; Toubes ME; Álvarez-Dobaño JM; Valdés L
    Arch Bronconeumol; 2017 Aug; 53(8):432-436. PubMed ID: 28238515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription patterns of oral anticoagulants for patients with non-valvular atrial fibrillation: experience at a Japanese single institution.
    Tagaya M; Yoshikawa D; Sugishita Y; Yamauchi F; Ito T; Kamada T; Yoshinaga M; Mukaide D; Fujiwara W; Yokoi H; Hayashi M; Watanabe E; Ishii J; Ozaki Y; Izawa H
    Heart Vessels; 2016 Jun; 31(6):957-62. PubMed ID: 26022376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.